NSABP COMMUNITY CLINICAL ONCOLOGY PROGRAM RESEARCH BASE

Information

  • Research Project
  • 7876928
  • ApplicationId
    7876928
  • Core Project Number
    U10CA037377
  • Full Project Number
    5U10CA037377-25
  • Serial Number
    37377
  • FOA Number
    RFA-CA-07-025
  • Sub Project Id
  • Project Start Date
    9/15/1983 - 40 years ago
  • Project End Date
    5/31/2012 - 12 years ago
  • Program Officer Name
    MCCASKILL-STEVENS, WORTA J.
  • Budget Start Date
    6/1/2010 - 14 years ago
  • Budget End Date
    5/31/2011 - 13 years ago
  • Fiscal Year
    2010
  • Support Year
    25
  • Suffix
  • Award Notice Date
    9/20/2010 - 13 years ago
Organizations

NSABP COMMUNITY CLINICAL ONCOLOGY PROGRAM RESEARCH BASE

DESCRIPTION (provided by applicant): The National Surgical Adjuvant Breast and Bowel Project (NSABP) is an NCI-funded clinical trials cooperative group for cancer treatment and prevention and control research. The group has a more than 40- year history of conducting large-scale controlled treatment trials that have improved the treatment of patients with breast or colorectal cancer and have provided a better understanding of tumor biology. In 1992, the MSABP extended its research agenda to include cancer prevention trials. The NSABP has been a CCOP Research Base since the inception of the CCOP Program and 60 CCOPs currently list the NSABP among their research bases. CCOP participation in NSABP treatment and prevention trials is substantial;approximately 33% of NSABP accrual is attributable to CCOP investigators. This application requests continued funding for the NSABP to continue as a CCOP Research Base for the period June 1, 2007, through May 31, 2012. During the proposed grant period, the NSABP will: 1) continue to design and implement multi-institutional cancer treatment and prevention and control clinical trials;2) analyze, report, and publish the results of current NSABP studies;3) implement recruitment mechanisms and procedures to achieve adequate accrual and foster the participation of women and minorities in NSABP clinical trials;4) maintain data collection, data monitoring, and quality control procedures that are in compliance with federal guidelines;5) monitor CCOP performance through ongoing quality assurance programs;and, 6) continue the integration of CCOP investigators into the overall functioning of the NSABP.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    U10
  • Administering IC
    CA
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    5425084
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    999
  • Ed Inst. Type
  • Funding ICs
    NCI:5425084\
  • Funding Mechanism
    Other Research Related
  • Study Section
    ZCA1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    NSABP FOUNDATION, INC.
  • Organization Department
  • Organization DUNS
    107186988
  • Organization City
    PITTSBURGH
  • Organization State
    PA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    152125256
  • Organization District
    UNITED STATES